Epigenetics make transient states of cancer therapy resistance permanent.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 28659441.
- Also identified by DOI 10.1126/scitranslmed.aan6729.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Resistance to targeted cancer therapies is mediated by stabilization of transient insensitive states.
Medical subject headings
- Drug Resistance, Neoplasm
- Molecular Targeted Therapy